Dr Irina Klebanov, DO | |
1517 Voorhies Ave, Brooklyn, NY 11235-3970 | |
(718) 676-4500 | |
(718) 942-5649 |
Full Name | Dr Irina Klebanov |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 39 Years |
Location | 1517 Voorhies Ave, Brooklyn, New York |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013955285 | NPI | - | NPPES |
02221167 | Medicaid | NY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 223026 (New York) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Fayn Medical Pc | 8527140227 | 4 |
News Archive
"The non-communicable disease [NCD] community always talks about the importance of prevention; many consider it the Holy Grail in the fight against NCDs. Why was it so hard to also accept treatment as part of the solution?" Princess Dina Mired, director general of the King Hussein Cancer Foundation in Amman, Jordan, asks in the Huffington Post "Impact" blog, noting only one target of the 2011 U.N. High-Level Meeting on NCDs "deals with treatment, the target on 'essential medicines and basic technologies for treatment.'"
Northwestern Medicine scientists have discovered a new pathway in the brain that can be manipulated to alleviate depression. The pathway offers a promising new target for developing a drug that could be effective in individuals for whom other antidepressants have failed.
The 32ed Annual Scientific Meeting of the American Pain Society will convene May 8-11 at the New Orleans Convention Center.
OncoGenex Pharmaceuticals, Inc. today provided an update on current events and activities and announced its second quarter financial results.
› Verified 3 days ago
Entity Name | Fayn Medical Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1538198635 PECOS PAC ID: 8527140227 Enrollment ID: O20080204000386 |
News Archive
"The non-communicable disease [NCD] community always talks about the importance of prevention; many consider it the Holy Grail in the fight against NCDs. Why was it so hard to also accept treatment as part of the solution?" Princess Dina Mired, director general of the King Hussein Cancer Foundation in Amman, Jordan, asks in the Huffington Post "Impact" blog, noting only one target of the 2011 U.N. High-Level Meeting on NCDs "deals with treatment, the target on 'essential medicines and basic technologies for treatment.'"
Northwestern Medicine scientists have discovered a new pathway in the brain that can be manipulated to alleviate depression. The pathway offers a promising new target for developing a drug that could be effective in individuals for whom other antidepressants have failed.
The 32ed Annual Scientific Meeting of the American Pain Society will convene May 8-11 at the New Orleans Convention Center.
OncoGenex Pharmaceuticals, Inc. today provided an update on current events and activities and announced its second quarter financial results.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Irina Klebanov, DO 155 Oceana Dr E, 6c, Brooklyn, NY 11235-6684 Ph: (718) 496-7679 | Dr Irina Klebanov, DO 1517 Voorhies Ave, Brooklyn, NY 11235-3970 Ph: (718) 676-4500 |
News Archive
"The non-communicable disease [NCD] community always talks about the importance of prevention; many consider it the Holy Grail in the fight against NCDs. Why was it so hard to also accept treatment as part of the solution?" Princess Dina Mired, director general of the King Hussein Cancer Foundation in Amman, Jordan, asks in the Huffington Post "Impact" blog, noting only one target of the 2011 U.N. High-Level Meeting on NCDs "deals with treatment, the target on 'essential medicines and basic technologies for treatment.'"
Northwestern Medicine scientists have discovered a new pathway in the brain that can be manipulated to alleviate depression. The pathway offers a promising new target for developing a drug that could be effective in individuals for whom other antidepressants have failed.
The 32ed Annual Scientific Meeting of the American Pain Society will convene May 8-11 at the New Orleans Convention Center.
OncoGenex Pharmaceuticals, Inc. today provided an update on current events and activities and announced its second quarter financial results.
› Verified 3 days ago
Dr. Simon Fensterszaub, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 432 Bedford Ave, Brooklyn, NY 11249 Phone: 718-964-6161 Fax: 718-387-9222 | |
David Streicher, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1312 38th St, Brooklyn, NY 11218 Phone: 718-686-7600 | |
Michael Conrad, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 8012 3rd Ave, Brooklyn, NY 11209 Phone: 718-745-5600 | |
Dr. Allen L Lee, MD DIPLOMATEABFP Family Medicine Medicare: Medicare Enrolled Practice Location: 433 72nd St, Brooklyn, NY 11209 Phone: 718-748-1320 Fax: 718-321-0341 | |
Larisa Veksman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 162 Brighton 11street, 1st Floor, Brooklyn, NY 11235 Phone: 212-686-6700 Fax: 646-349-2066 | |
Oleg Kotelskiy, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3816 Nostrand Ave, Brooklyn, NY 11235 Phone: 718-338-2323 Fax: 718-338-7117 | |
Dr. Farideh Zonouzi-zadeh, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 374 Stockholm St, C/o Faculty Practice, Brooklyn, NY 11237 Phone: 718-963-6551 Fax: 718-963-6793 |